NYR 26.4% 11.0¢ nyrada inc.

Nyrada Talks PreClinical Success with 180 Markets, page-79

  1. 6,293 Posts.
    lightbulb Created with Sketch. 1274
    Thanks for the Neuren info. My memory was right, it was the USA Army facility ( Walter Reed Army Medical Centre) that teamed up with Neuren and what a massive multibagger that proved to be. So now, in the same field of research ( TBI) they are now collaborating with NYR. Could not get a better collaborative team on board, world - class by far in the neurology R&D field. Mr ASX Market by and large is still unaware of this fact. The US Army would have a very strict filter system for would - be collaborative R&D and that speaks volumes for what they they see so far with NYR. I also note the reference by posters to ADX in their collaboration with Walter Reed facility, but we are talking different approaches... ADX is trialling peptides, we are trialling "small molecules" . Vastly different.
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.